— Know what they know.
Not Investment Advice

JAZZ NASDAQ

Jazz Pharmaceuticals plc
1W: -3.3% 1M: -13.2% 3M: -19.2% YTD: +19.4% 1Y: +49.3% 3Y: +54.8% 5Y: +43.6%
$206.78
+1.08 (+0.53%)
After Hours: $212.87 (+6.09, +2.94%)
Weekly Expected Move ±3.7%
$198 $206 $214 $222 $230
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 35 · $13.4B mcap · 62M float · 1.39% daily turnover · Short 50% of daily vol
Credit Risk of going bust: lower than 57% of companies Debt: 24.8% of company value Bonds: $459.8M held by 158 funds, 99 bp over Treasuries → details ▾
If the stock fell to about $5.81 (down 97%), Jazz Pharmaceuticals plc would be worth roughly what it owes.
Total debt $4.41B against a stock market value of $13.35B.
Distance to default 5.84 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.68B (short-term plus half of long-term), stock volatility 36.3%; Altman Z'' 2.72. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Oct Typical
☀️
Sunny
+22.9% YTD avg
Midterm Year
☀️
Sunny
+20.6% YTD avg
2026 Now
☀️
Sunny
Below typical
20yr Avg YTD
+22.9%
Day 206 of 252
Midterm Year YTD
+20.6%
Presidential cycle avg
2026 YTD
+19.4%
Below 20yr avg
Typical Vol
58%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+1.0%
Midterm
☀️
+13.1%
58% win 54% vol
Feb
20yr
💨
+2.9%
Midterm
☀️
+17.8%
58% win 48% vol
Mar
20yr
💨
+2.1%
Midterm
☀️
+17.3%
58% win 64% vol
Apr
20yr
⛈️
+2.3%
Midterm
☀️
+16.8%
58% win 49% vol
May
20yr
💨
+0.6%
Midterm
☀️
+11.8%
47% win 52% vol
Jun
20yr
💨
+11.0%
Midterm
☀️
+16.6%
55% win 180% vol
Jul
20yr
💨
+20.2%
Midterm
☀️
+15.4%
65% win 53% vol
Aug
20yr
💨
+26.5%
Midterm
☀️
+20.0%
50% win 47% vol
Sep
20yr
⛈️
+27.4%
Midterm
☀️
+20.2%
30% win 55% vol
Oct
20yr
⛈️
+22.2%
Midterm
☀️
+20.8%
35% win 58% vol
Now: -10.7%
Nov
20yr
💨
+32.5%
Midterm
☀️
+42.0%
63% win 67% vol
Dec
20yr
💨
+2.5%
Midterm
⛈️
-1.5%
53% win 70% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +19.4%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms